Anthropic expands Claude AI into drug development to identify research bottlenecks
Anthropic is expanding Claude's role across several stages of drug development Generate Biomedicines reports a 70% reduction in CAR T-cell component length Modified immune cells produced roughly ten times more cancer-detecting receptors Anthropic is expanding Claude’s involvement in pharmaceutical…
Fire or Trash?
Your verdict on this story. One tap, no account needed.Dumpster Fire links to reporting from TechRadar. We don’t rewrite the facts; the original story is one click away.
Comments
Loading comments…
Comments are automatically checked for hate, threats and spam. Community rules.